Abstract
Familial hypercholesterolemia (FH) is a common inherited disorder, yet the diagnosis methods and management are still challenging. The heterozygous FH (known as FH) is more common than the homozygous form, yet a mutation only found in only about 40% of patients with the phenotype of FH. In fact, most cases are most likely caused by polygenic aetiology with less severe clinical presentations than monogenic FH. Therefore, understanding FH is essential, so that the diagnosis methods and management, particularly the patients’ preventive measures of the patients can be improved. This review aims to describe and discuss the type of FH, including the clinical and lipid presentation, molecular pathogenesis of monogenic FH, and further discussion on how polygenic FH should be diagnosed and managed. Keywords: hypercholesterolemia, SNP, DNA testing
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
